Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 10, 2021

View Archived Issues

HDAC6 linked to higher risk of relapse in HER2-positive breast cancer treated with trastuzumab

Shanghai Institutes for Biological Sciences presents islet-like cell clusters

iNtRON Biotechnology patents Myoviridae bacteriophage compositions

New BRD4 BD2 inhibitors discovered at Betta Pharmaceuticals

Medshine Discovery identifies new CCR5/CCR1 antagonists

Beijing Findcure Biosciences divulges tyrosine-protein kinase receptor UFO inhibitors

NCC-1566 demonstrates synergistic effect with levetiracetam in pharmacoresistant 6 Hz model

Stomach organoid created from multiple stem cell types

Mdm2 gene amplification is associated with poor outcome of patients with luminal breast cancer

lncRNA XIST could be used to select triple-negative breast cancer patients for ERbeta therapy

MDX-124 shows efficacy in preclinical models of TNBC

BetterLife's TD-0148A reverses depressive-like behavior in chronically stressed mice

Totus receives financing to advance TOS-358 drug program for cancer

CRISPR-Cas9 gRNA system eliminates diverse proviral HIV-1 strains

NextVivo launches to develop immune organoid technology platform

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...